Abstract
The kinetic analysis of esterase inhibition by acylating compounds (organophosphorus carbamates and sulfonyl fluorides) is sometimes unable to yield consistent results by fitting simple inhibition kinetic models to experimental data of complex systems. In this work, kinetic data were obtained for phenylmethylsulfonyl fluoride (PMSF) tested at different concentrations incubated for up to 3 h with soluble fraction of chicken peripheral nerve. PMSF is a protease and esterase inhibitor causing protection or potentiation of the organophosphorus-induced delayed neuropathy and is unstable in water solution. The target of the promotion effect was proposed to be a soluble esterase not yet identified. A kinetic model equation was deduced assuming a multienzymatic system with three different molecular phenomena occurring simultaneously: (1) inhibition, (2) spontaneous chemical hydrolysis of the inhibitor and (3) ongoing inhibition (inhibition during the substrate reaction). A three-dimensional fit of the model was applied for analyzing the experimental data. The best-fitting model is compatible with a resistant component (16.5–18%) and two sensitive enzymatic entities (both 41%). The corresponding second-order rate constants of inhibition (ki = 12.04 × 10−2 and 0.54 × 10−2 μM−1 min−1, respectively) and the chemical hydrolysis constant of PMSF (kh = 0.0919 min−1) were simultaneously estimated. These parameters were similar to those deduced in fixed-time inhibition experiments. The consistency of results in both experiments was considered an internal validation of the methodology. The results were also consistent with a significant ongoing inhibition. The proportion of enzymatic components showed in this work is similar to those previously observed in inhibition experiments with mipafox, S9B and paraoxon, demonstrating that this kinetic approach gives consistent results in complex enzymatic systems.
Similar content being viewed by others
References
Aldridge WN, Reiner E (1972) Enzyme inhibitors as substrates. North-Holland, Amsterdam
Barril J, Vilanova E (1997) Reversible inhibition can profoundly mislead studies on progressive inhibition of enzymes: the interaction of paraoxon with soluble neuropathy target esterase. Chem Biol Interact 108:19–25
Barril J, Estévez J, Escudero MA, Céspedes MV, Ñíguez N, Sogorb MA, Monroy A, Vilanova E (1999) Peripheral nerve soluble esterases are spontaneously reactivated after inhibition by paraoxon: implication for a new definition of neuropathy target esterase. Chem Biol Interact 119–120:541–550
Bazire A, Gillon E, Lockridge O, Vallet V, Nachon F (2011) The kinetic study of the inhibition of human cholinesterases by demeton-S-methyl shows that cholinesterase-based titration methods are not suitable for this organophosphate. Toxicol In Vitro 25(3):754–759
Carrera V, Barril J, Mauricio M, Pellín M, Vilanova E (1992) Local application of neuropathic organophosphorus compounds to hen sciatic nerve: inhibition of neuropathy target esterase and peripheral neurological impairments. Toxicol Appl Pharmacol 117(2):218–225
Escudero MA, Céspedes MV, Vilanova E (1997) Chromatographic discrimination of soluble neuropathy target esterase isoenzymes and related phenyl valerate esterases from chicken brain, spinal cord, and sciatic nerve. J Neurochem 68(5):2170–2176
Estévez J, Vilanova E (2009) Model equations for the kinetics of covalent irreversible enzyme inhibition and spontaneous reactivation: esterases and organophosphorus compounds. Crit Rev Toxicol 39(5):427–448
Estévez J, García-Pérez AG, Barril J, Pellín M, Vilanova E (2004) The inhibition of the high sensitive peripheral nerve soluble esterases by mipafox: a new mathematical processing for the kinetics of inhibition of esterases by organophosphorus compounds. Toxicol Lett 151:171–181
Estévez J, Barril J, Vilanova E (2010) Inhibition with spontaneous reactivation and the “ongoing inhibition” effect of esterases by biotinylated organophosphorus compounds: S9B as a model. Chem Biol Interact 187:397–402
Estévez J, García-Pérez A, Barril J, Vilanova E (2011) Inhibition with spontaneous reactivation of carboxyl esterases by organophosphorus compounds: paraoxon as a model. Chem Res Toxicol 24:135–143
Eyer P, Radtke M, Worek F (2008) Reactions of isodimethoate with human red cell acetylcholinesterase. Biochem Pharmacol 75:2045–2053
Gambalunga A, Pasqualato F, Lotti M (2010) Soluble phenyl valerate esterases of hen sciatic nerve and the potentiation of organophosphate induced delayed polyneuropathy. Chem Biol Interact 187:340–343
Glynn P, Read DJ, Guo R, Wylie S, Johnson MK (1994) Synthesis and characterization of a biotinylated organophosphorus ester for detection and affinity purification of a brain serine esterase: neuropathy target esterase. Biochem J 301:551–556
Glynn P, Read DJ, Lush MJ, Li Y, Atkins J (1999) Molecular cloning of neuropathy target esterase (NTE). Chem Biol Interact 119–120:513–517
James GT (1978) Inactivation of the protease inhibitor phenylmethylsulfonyl fluoride in buffers. Anal Biochem 86(2):574–579
Johnson MK (1969) The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. Biochem J 114:711–717
Johnson MK (1977) Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. Arch Toxicol 37:113–115
Johnson MK (1982) The target for initiation of delayed neurotoxicity by organophosphorus esters: biochemical studies and toxicological applications. Rev Biochem Toxicol 4:141–212
Johnson MK (1987) Receptor or enzyme: the puzzle of NTE and organophosphorus-induced delayed polyneuropathy target esterase of hen brain. Trends Pharmacol Sci 8:174–179
Kropp TJ, Glynn P, Richardson RJ (2004) The mipafox-inhibited catalytic domain of human neuropathy target esterase ages by reversible proton loss. Biochemistry 43(12):3716–3722
Lotti M, Caroldi S, Capodicasa E, Moretto A (1991) Promotion of organophosphate-induced delayed polyneuropathy by phenylmethanesulfonyl fluoride. Toxicol Appl Pharmacol 108:234–241
Lush MJ, Li Y, Read DJ, Willis AC, Glynn P (1998) Neuropathy target esterase and a homologous Drosophila neurodegeneration-associated mutant protein contain a novel domain conserved from bacteria to man. Biochem J 15, 332 (Pt 1):1–4
Milatovic D, Moretto A, Osman KA, Lotti M (1997) Phenyl valerate esterases other than neuropathy target esterase and the promotion of organophosphate polyneuropathy. Chem Res Toxicol 10:1045–1048
Moretto A (2000) Promoters and promotion of axonopaties. Toxicol Lett 112(113):17–21
Moretto A, Gardiman G, Panfilo S, Colle MA, Lock EA, Lotti M (2001) Effects of S-ethyl hexahydro-1H-azepine-1-carbothioate (molinate) on di-n-butyl dichlorovinyl phosphate (DBDCVP) neuropathy. Toxicol Sci 62(2):274–279
Pope CN, Padilla S (1990) Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethylsulfonyl fluoride. J Toxicol Environ Health 31:261–273
Williams DG, Johnson MK (1981) Gel electrophoretic identification of hen brain neurotoxic esterase labeled with tritiated diisopropylphosphofluridate. Biochem J 199(2):323–333
Conflict of interest
The authors declare that there are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Estévez, J., Barril, J. & Vilanova, E. Kinetics of inhibition of soluble peripheral nerve esterases by PMSF: a non-stable compound that potentiates the organophosphorus-induced delayed neurotoxicity. Arch Toxicol 86, 767–777 (2012). https://doi.org/10.1007/s00204-012-0817-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-012-0817-3